Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase

Details for Australian Patent Application No. 2003212335 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Meerpoel, Lieven; Dyatkin, Alexey, Borisovich; Van Emelen, Kristof; Van heusden, Jimmy Arnold Viviane; Verdonck, Marc, Gustaaf, Celine; De Winter, Hans, Louis, Jos

Agent Shelston IP

Pub. Number AU-B-2003212335

PCT Number PCT/EP03/02511

PCT Pub. Number WO2003/076421

Priority 60/363,799 13.03.02 US

Filing date 11 March 2003

Wipo publication date 22 September 2003

Acceptance publication date 27 November 2008

International Classifications

C07D 249/12 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4545 (2006.01)

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/02 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/02 Drugs for disorders of the respiratory system

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 60/363,799 13.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003212335

18 August 2005 Amendment Made

  The nature of the amendment is: Add co-inventor Van heusden, Jimmy Arnold Viviane

27 November 2008 Application Accepted

  Published as AU-B-2003212335

2 April 2009 Standard Patent Sealed

23 April 2009 Corrigenda

  Applications Accepted - Name Index Under the name Janssen Pharmaceutica N.V., Application No. 2003212335, under INID(72), correct the co-inventor name to Van heusden, Jimmy Arnold Viviane

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003212336-Carbonylamino-derivatives as novel inhibitors of histone deacetylase

2003212334-CATALYST AND METHOD FOR PRODUCING MALEIC ANHYDRIDE